Improved site-specific recombinase-based method to produce selectable marker- and vector-backbone-free transgenic...

Area of Science:

• Biotechnology
• Molecular Biology
• Gene Therapy

Background:

• PhiC31 integrase is widely used for gene therapy and animal transgenesis.
• Random integration events in phiC31-mediated gene delivery reduce efficiency and complicate evaluation.
• Existing methods require improvement for precise and efficient site-specific integration.

Purpose of the Study:

• To enhance the phiC31 integrase system for precise gene delivery.
• To eliminate random integration events and selectable markers in mammalian cells.
• To generate clean transgenic cells for applications in gene therapy and agricultural biotechnology.

Main Methods:

• Utilized an attB-TK fusion gene as a negative selection marker to eliminate random integration.
• Employed Cre and Dre recombinases to excise the selection system and plasmid bacterial backbone.
• Generated transgenic bovine fetal fibroblast cells free of unwanted genetic material.

Main Results:

• Successfully eliminated random integration events during phiC31-mediated transfection.
• Created clean transgenic cells devoid of selectable markers and plasmid bacterial backbone.
• Demonstrated that these clean cells maintain developmental competence for somatic cell nuclear transfer (SCNT).

Conclusions:

• The improved gene delivery system enhances the efficiency and precision of phiC31 integrase-mediated gene transfer.
• This method facilitates the development of robust gene therapy strategies.
• The system holds significant potential for advancing agricultural biotechnology through precise transgenesis.